1. Prevention of COPD. Available from: http://www.goldcopd.org, Accessed January 29, 2013
2. Dalal AA, Shah M, D’Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med. 2011;105(3):454-60.
3. Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide impatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest. 2015;147(4):989-98.
4. Global Initiative for Chronic Obstructive Lung Disease, Inc. Pocket guide to COPD diagnosis, management, and prevention: A guide for healthcare professionals, 2018. Accessed at www.goldcopd.org.
5. Safka KA, Wald J, Wang H, McIvor L, McIvor A. GOLD stage and treatment in COPD: a 500 patient point prevalence study. Chronic Obstr. Pulm. Dis. 4(1), 45–55 (2016).
6. Simeone JC, Luthra R, Kaila S, et al. Initiation of triple therapy maintenance treatment among patients with COPD in the US. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 73–83 (2017).

The authors wish to thank Sharanya Murali, MS for project management services and Felix Cao, PhD, Jim Hartje MS, Vincent Peichel BS, and Damon van Voorhis BS for programming and Ginny Rosen, PhD for poster design services.

This study was funded by Boehringer Ingelheim Pharmaceuticals, Inc. The author(s) meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors received no direct compensation related to the development of the poster. Writing, editorial support, and formatting assistance for this poster was provided by Virginia Rosen, PhD of Optum, which was contracted and compensated by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI), for these services. BIPI was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations.